Shigella Surge? What to Know About Drug-Resistant 'Sexually Transmitted Diarrhea'

Drug-resistant Shigella infections cause severe diarrhea, fever, and complications requiring hospitalization; vulnerable populations including unhoused people and children under 5 face elevated risk.
Close to untreatable over the course of a decade
A Cambridge researcher describes how Shigella has shifted from easily treatable to resistant to nearly all available antibiotics.
Mark

So the headlines say there's a surge, but the numbers don't actually show that. What's driving all the noise?

Mimi

One or two sources revisited existing research about drug resistance and it spread online. The CDC report came out in April, studies have been published over the past couple years, but something triggered a wave of attention this week. It's the same information, just circulating again.

Luke

But we should be careful here—stable case numbers don't mean the problem isn't serious. The real story is the resistance, not the volume.

Mark

Right. So what's actually changed with the bacteria itself?

Mimi

The resistance has grown dramatically. In 2011, zero percent of tested samples showed extensive drug resistance. By 2023, it was 8.5 percent. That's resistance to all FDA-approved antibiotics.

Luke

That's a significant shift, but I want to be precise: 8.5 percent of what? How many samples were tested? The source doesn't specify the denominator, so we know the direction but not the absolute scale.

Mark

And this is mostly affecting one community?

Mimi

Men who have sex with men, yes. About 86 percent of extensively resistant cases occurred in men. A UK study found that by 2020, roughly 70 percent of sexually transmitted Shigella strains were resistant to at least one antibiotic.

Luke

The UK study is important context, but it's one study over a specific time period. We should note that most of what we know about sexually transmitted Shigella comes from recent research. This isn't a decades-old pattern.

Mark

Why is it spreading sexually now when it wasn't before?

Mimi

Experts started noticing it around the turn of the century. They always knew it could spread through sexual contact, but they thought it was rare. It turns out it wasn't. The mechanism involves something called bystander resistance—when the wrong antibiotic or wrong dose is used, the bacterium survives and develops resistance.

Luke

That's a plausible explanation, but I'd want to know: is bystander resistance the only driver, or are there others? The source points to it as one factor, not necessarily the whole picture.

Mark

What should people actually do about this?

Mimi

Hand washing is the main thing. Thorough washing with soap and water after the bathroom, before eating, before and after sex. If you're sick, don't have sex for at least two weeks after symptoms stop.

Luke

That's solid prevention advice, but it assumes people know they have Shigella or suspect they might. How many people actually get tested? How many think it's just food poisoning?

Mark

So what happens next?

Mimi

Health experts in the US and UK are working to understand the resistant strains better and develop new treatment tools. In the meantime, this will keep surfacing in headlines whenever diarrheal illness appears in the news.

Luke

The real question is whether the public health response will reach the communities most affected before resistance becomes even more entrenched.

  • Social media amplified fears of a Shigella surge, but federal data shows case counts are essentially flat compared to last year — the real story is quieter and more troubling.
  • Drug resistance is the genuine crisis: in just over a decade, the share of extensively resistant Shigella strains climbed from zero to 8.5 percent, with some infections now offering clinicians almost no reliable treatment options.
  • Men who have sex with men account for the overwhelming majority of drug-resistant cases, yet many in that community remain unaware of the risk, leaving a critical gap in prevention.
  • Vulnerable groups — unhoused individuals and children under five — face compounding dangers as resistant strains spread beyond the communities where they first emerged.
  • Public health authorities on both sides of the Atlantic are racing to develop new treatment tools and targeted messaging before the window for manageable intervention closes further.

A bacterium long associated with childhood illness and international travel has quietly evolved into something more difficult to contain and, in some cases, nearly impossible to treat. Shigella — which spreads through microscopic fecal contact and now increasingly through sexual transmission — has not surged in raw numbers, but the strains circulating today are far more resistant to antibiotics than those of a decade ago. The alarm is not about a new outbreak but about a slow, structural shift in how a familiar pathogen behaves, and who bears the heaviest burden of its consequences.

Headlines about sexually transmitted diarrhea have flooded health news feeds, but the federal data tells a calmer story: as of late September 2026, U.S. Shigella case counts stood at roughly 13,900 — nearly identical to the prior year. The wave of alarm appears to trace back to existing research cycling through social media rather than any genuine new outbreak. The CDC did release a report on drug-resistant strains earlier this year, and related studies have followed, but the noise is largely informational recycling rather than a signal of fresh crisis.

What is genuinely new — and genuinely serious — is how the bacterium has changed. Shigella causes shigellosis, an intestinal infection marked by acute diarrhea, fever, and stomach pain that can last weeks and occasionally requires hospitalization. It spreads with startling ease: a tiny amount of the bacterium is enough to make someone sick, and an infected person can shed it in stool for up to two weeks after symptoms fade. For most of its history in the United States, it primarily struck children under five and people exposed through international travel.

That profile has shifted. Sexual transmission, once considered theoretically possible but rare, has become a meaningful route of spread — particularly among men who have sex with men. A Lancet Infectious Diseases study found that by the end of a 2015–2020 study period, roughly 70 percent of sexually transmitted Shigella strains showed resistance to at least one antibiotic, compared to 40 percent in non-sexual cases. More alarming still, the share of strains resistant to all FDA-approved antibiotics rose from zero percent in 2011 to 8.5 percent in 2023, with men accounting for more than 86 percent of those cases.

Researchers point to a mechanism called bystander resistance: when an antibiotic fails to fully eliminate Shigella — whether because it was the wrong drug, the wrong dose, or prescribed for an unrelated condition — the surviving bacteria adapt and harden. A Cambridge University researcher described the trajectory bluntly: a disease that was readily treatable a decade ago has become close to untreatable for some patients.

Prevention, for now, remains low-tech. Thorough handwashing, avoiding swallowing water in natural bodies, and pausing sexual contact until diarrhea has been gone for at least two weeks are the primary tools available. Health authorities in the U.S. and U.K. are working to develop better treatments and to reach communities most at risk with clearer messaging. Until those efforts bear fruit, Shigella will likely keep resurfacing in the news — not because of a new outbreak, but because the underlying problem has grown harder to solve.

The internet has been buzzing about sexually transmitted diarrhea. If you've scrolled through health news in recent days, you've likely encountered alarming headlines about a Shigella surge, drug-resistant strains, and rising case counts. The reality, according to federal disease tracking data, is more measured—and yet still serious in ways that deserve attention.

Shigella is a bacterium that causes shigellosis, an infection of the digestive system marked by acute diarrhea, fever, stomach pain, and sometimes complications severe enough to require hospitalization. The illness spreads easily between people through contaminated surfaces, food, water, or microscopic fecal particles. A person needs only a small amount of the bacterium to become sick. Most people recover at home, though symptoms—which typically begin one to two days after exposure—can last anywhere from a few days to four weeks or longer. The bacteria can be shed in stool for up to two weeks after symptoms disappear, making infected people contagious even as they feel better.

As of September 26, 2026, the Centers for Disease Control and Prevention had recorded 13,921 cases of shigellosis in the United States. That number sits roughly even with the previous year's total of 14,277 cases. The recent surge in headlines and social media posts appears to stem from one or two sources revisiting existing research about drug resistance and antibiotic-resistant strains, reigniting public interest rather than reflecting a genuine spike in infections. The CDC did publish a report on drug-resistant Shigella in April, and related studies have emerged over the past year or two, but the current wave of attention is largely a product of information cycling through the internet rather than new outbreak data.

What has genuinely shifted, however, is the bacterium's resistance to treatment. In 2011, zero percent of tested Shigella samples showed extensive drug resistance—meaning resistance to all FDA-approved antibiotics. By 2023, that figure had climbed to 8.5 percent. This matters because it means some infections have become far harder to treat. The vast majority of these extensively resistant cases, 86.2 percent, occurred in men. Recent research, including a study published in The Lancet Infectious Diseases in July, found that drug-resistant strains are significantly more prevalent among men who have sex with men. By the end of a 2015-2020 study period, roughly 70 percent of sexually transmitted Shigella strains showed resistance to at least one antibiotic, compared to 40 percent among non-sexually transmitted cases and 49 percent among travel-related infections.

The emergence of sexual transmission as a significant route for Shigella spread is relatively recent. For decades, most U.S. cases occurred in children under five or in people who had traveled internationally or been exposed to travelers. Around the turn of the century, experts began documenting its spread through sexual contact—something scientists knew was theoretically possible but believed happened rarely. That assumption has proven wrong. The mechanism driving resistance in these communities involves what researchers call bystander resistance: when the wrong antibiotic or incorrect dose is used to treat Shigella, or when an antibiotic prescribed for another condition fails to eliminate the bacterium, the germ survives and develops resistance.

Certain populations face elevated risk. The unhoused and children under five are particularly vulnerable. Health experts in both the United States and the United Kingdom have begun sounding alarms about the trajectory of the disease. One Cambridge University researcher noted in a July press release that Shigella has shifted from being readily treatable with standard medications to becoming nearly untreatable within roughly a decade. Many men who have sex with men remain unaware of the growing risk posed by sexually transmitted Shigella, experts say, making targeted public health messaging essential.

Prevention remains straightforward: thorough hand washing with soap and running water after using the bathroom, changing diapers, before and after handling food, and before and after sexual contact. People should avoid swallowing water in pools, lakes, rivers, or ponds. If someone becomes sick, sexual contact should stop and resume only after diarrhea symptoms have ceased for at least two weeks. Health authorities on both sides of the Atlantic are working to better understand the resistant strains and develop new tools to slow their spread. Until then, the disease will likely continue surfacing in headlines whenever diarrheal illness appears in the news—not because of a current outbreak, but because the underlying problem has become harder to solve.

This disease has gone from being relatively treatable with off-the-shelf drugs to being close to untreatable over the course of the last decade or so.
— Cambridge University researcher and study author, July 2026
Many men who have sex with men are unaware of the serious and increasing risk posed by sexually transmitted shigella. It is vital that this message reaches the communities most affected.
— Cambridge University researcher, July 2026
Möchten Sie die ganze Geschichte? Das Original lesen bei USA Today ↗
Kontakt FAQ